Tapewire

NYSE · USD

EW

Edwards Lifesciences Corp

Export transactions ↓
Tapewire entity
3026
SEC CIK
0001099800
Parsed reports
947

Last 12 months

Inside the activity.

0 purchase rows · 54 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 2025010
Jan 202603
Feb 202603
Mar 202604
Apr 202605
May 2026012
Jun 202602
Jul 202604
Aug 202606
Sep 202601
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 08, 2022 Filed Mar 8, 2022 23:44 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 1,695 $105.23 $178,362.31
Disclosure

SEC source: 0001225208-22-004392 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,979.42

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $104.84 to $105.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 08, 2022 Filed Mar 8, 2022 23:44 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 7,242 $36.75 $266,143.50
Disclosure

SEC source: 0001225208-22-004392 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,674.42

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

Read SEC document
February 21, 2022 Filed Feb 22, 2022 23:36 UTC
Ullem Scott B.CVP, Chief Financial Officer
Tax withholdingCommon Stock 319 $105.62 $33,692.78
Disclosure

SEC source: 0001225208-22-002983 · doc4.xml · nonDerivative · entry 1

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,812

Read SEC document
February 18, 2022 Filed Feb 19, 2022 00:41 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 20,000 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-22-002824 · doc4.xml · derivative · entry 4

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,400

Underlying: Common Stock · 20,000 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2022 Filed Feb 19, 2022 00:41 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 13,100 $106.62 $1,396,673.53
Disclosure

SEC source: 0001225208-22-002824 · doc4.xml · nonDerivative · entry 3

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,414.5223

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $106.19 to $107.00 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 18, 2022 Filed Feb 19, 2022 00:41 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 6,900 $105.74 $729,579.09
Disclosure

SEC source: 0001225208-22-002824 · doc4.xml · nonDerivative · entry 2

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,514.5223

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $105.19 to $106.16. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 18, 2022 Filed Feb 19, 2022 00:41 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionCommon Stock 20,000 $21.76 $435,200.00
Disclosure

SEC source: 0001225208-22-002824 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,414.5223

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

Read SEC document
February 15, 2022 Filed Feb 16, 2022 01:50 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 45,050 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-22-002224 · doc4.xml · derivative · entry 7

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,150

Underlying: Common Stock · 45,050 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2022 Filed Feb 16, 2022 01:50 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002224 · doc4.xml · nonDerivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Living Trust

Disclosed balance after: 3,369,017

Read SEC document
February 15, 2022 Filed Feb 16, 2022 01:50 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 25,756 $109.95 $2,831,872.20
Disclosure

SEC source: 0001225208-22-002224 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,271.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $109.375 to $110.375. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 15, 2022 Filed Feb 16, 2022 01:50 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002224 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,027.82

Read SEC document
February 15, 2022 Filed Feb 16, 2022 01:50 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 6,794 $110.60 $751,416.40
Disclosure

SEC source: 0001225208-22-002224 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,527.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $110.380 to $110.850. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 15, 2022 Filed Feb 16, 2022 01:50 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 45,050 $21.76 $980,288.00
Disclosure

SEC source: 0001225208-22-002224 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,321.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

Read SEC document
February 11, 2022 Filed Feb 12, 2022 01:53 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 11,050 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-22-001971 · doc4.xml · derivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,100

Underlying: Common Stock · 11,050 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 11, 2022 Filed Feb 12, 2022 01:53 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 10,650 $111.47 $1,187,124.62
Disclosure

SEC source: 0001225208-22-001971 · doc4.xml · nonDerivative · entry 3

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,399.3995

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $110.990 to $111.975. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F4 · balance_after: Reflects a correction of a Bona fide gift previously filed for on January 31, 2022.

Read SEC document
February 11, 2022 Filed Feb 12, 2022 01:53 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 400 $112.00 $44,799.00
Disclosure

SEC source: 0001225208-22-001971 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,049.3995

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $111.990 to $112.000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 11, 2022 Filed Feb 12, 2022 01:53 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 11,050 $21.76 $240,448.00
Disclosure

SEC source: 0001225208-22-001971 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,449.3995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

Read SEC document
February 08, 2022 Filed Feb 9, 2022 01:19 UTC Exercise / conversionDirector Stock Option (Right to Acquire) · Derivative 32,256 $0.00 Strike: $22.29 $0.00
Disclosure

SEC source: 0001225208-22-001657 · doc4.xml · derivative · entry 4

GALLAHUE KIERAN · CIK 0001308428 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,256 shares

Expires 2022-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 08, 2022 Filed Feb 9, 2022 01:19 UTC SaleCommon Stock 32,256 $110.79 $3,573,509.99
Disclosure

SEC source: 0001225208-22-001657 · doc4.xml · nonDerivative · entry 2

GALLAHUE KIERAN · CIK 0001308428 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,433

F1 · price: This transaction was executed in multiple trades at prices ranging from $110.50 to $111.29. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 08, 2022 Filed Feb 9, 2022 01:19 UTC Exercise / conversionCommon Stock 32,256 $22.29 $718,879.80
Disclosure

SEC source: 0001225208-22-001657 · doc4.xml · nonDerivative · entry 1

GALLAHUE KIERAN · CIK 0001308428 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,689

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 08, 2022 Filed Feb 9, 2022 01:16 UTC
Wood Larry LCVP, TAVR
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 4,386 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-22-001656 · doc4.xml · derivative · entry 5

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,414

Underlying: Common Stock · 4,386 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 08, 2022 Filed Feb 9, 2022 01:16 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 4,086 $109.49 $447,387.17
Disclosure

SEC source: 0001225208-22-001656 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,432.42

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $108.96 to $109.94. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 08, 2022 Filed Feb 9, 2022 01:16 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 300 $110.31 $33,093.90
Disclosure

SEC source: 0001225208-22-001656 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,518.42

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $109.99 to $110.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 08, 2022 Filed Feb 9, 2022 01:16 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 4,386 $36.75 $161,185.50
Disclosure

SEC source: 0001225208-22-001656 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,818.42

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

Read SEC document
February 08, 2022 Filed Feb 9, 2022 01:12 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 6,350 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-22-001655 · doc4.xml · derivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,350 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 08, 2022 Filed Feb 9, 2022 01:12 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 6,350 $110.20 $699,770.00
Disclosure

SEC source: 0001225208-22-001655 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,026.8935

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Read SEC document
February 08, 2022 Filed Feb 9, 2022 01:12 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 6,350 $21.76 $138,176.00
Disclosure

SEC source: 0001225208-22-001655 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,376.8935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Read SEC document
January 28, 2022 Filed Feb 1, 2022 02:25 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 11,050 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-22-001213 · doc4.xml · derivative · entry 10

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,150

Underlying: Common Stock · 11,050 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 28, 2022 Filed Feb 1, 2022 02:25 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 4,092 $100.45 $411,054.90
Disclosure

SEC source: 0001225208-22-001213 · doc4.xml · nonDerivative · entry 7

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,399.3995

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F7 · price: This transaction was executed in multiple trades at prices ranging from $100.090 to $100.970. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 28, 2022 Filed Feb 1, 2022 02:25 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 3,058 $102.41 $313,172.84
Disclosure

SEC source: 0001225208-22-001213 · doc4.xml · nonDerivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,491.3995

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F6 · price: This transaction was executed in multiple trades at prices ranging from $102.340 to $102.655. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 28, 2022 Filed Feb 1, 2022 02:25 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 2,700 $101.73 $274,657.50
Disclosure

SEC source: 0001225208-22-001213 · doc4.xml · nonDerivative · entry 5

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,549.3995

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F5 · price: This transaction was executed in multiple trades at prices ranging from $101.340 to $102.190. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 28, 2022 Filed Feb 1, 2022 02:25 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 700 $99.54 $69,678.98
Disclosure

SEC source: 0001225208-22-001213 · doc4.xml · nonDerivative · entry 4

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,249.3995

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F4 · price: This transaction was executed in multiple trades at prices ranging from $99.070 to $100.000 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 28, 2022 Filed Feb 1, 2022 02:25 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 500 $98.23 $49,117.00
Disclosure

SEC source: 0001225208-22-001213 · doc4.xml · nonDerivative · entry 3

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,949.3995

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $97.730 to $98.360. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 28, 2022 Filed Feb 1, 2022 02:25 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 11,050 $21.76 $240,448.00
Disclosure

SEC source: 0001225208-22-001213 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,449.3995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

Read SEC document
January 14, 2022 Filed Jan 15, 2022 00:16 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 10,000 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-22-000769 · doc4.xml · derivative · entry 4

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,400

Underlying: Common Stock · 10,000 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 14, 2022 Filed Jan 15, 2022 00:16 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 8,884 $119.47 $1,061,328.84
Disclosure

SEC source: 0001225208-22-000769 · doc4.xml · nonDerivative · entry 3

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,414.5223

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $118.960 to $119.950. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 14, 2022 Filed Jan 15, 2022 00:16 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 1,116 $120.01 $133,934.40
Disclosure

SEC source: 0001225208-22-000769 · doc4.xml · nonDerivative · entry 2

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,298.5223

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $119.960 to $120.085. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 14, 2022 Filed Jan 15, 2022 00:16 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionCommon Stock 10,000 $21.76 $217,600.00
Disclosure

SEC source: 0001225208-22-000769 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,414.5223

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

Read SEC document
January 07, 2022 Filed Jan 7, 2022 23:06 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 6,350 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-22-000615 · doc4.xml · derivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,350

Underlying: Common Stock · 6,350 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 07, 2022 Filed Jan 7, 2022 23:06 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 6,350 $122.16 $775,716.00
Disclosure

SEC source: 0001225208-22-000615 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,026.8935

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Read SEC document
January 07, 2022 Filed Jan 7, 2022 23:06 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 6,350 $21.76 $138,176.00
Disclosure

SEC source: 0001225208-22-000615 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,376.8935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Read SEC document
January 06, 2022 Filed Jan 7, 2022 23:05 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 45,050 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-22-000614 · doc4.xml · derivative · entry 8

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,200

Underlying: Common Stock · 45,050 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 06, 2022 Filed Jan 7, 2022 23:05 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000614 · doc4.xml · nonDerivative · entry 6

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Living Trust

Disclosed balance after: 3,247,787

Read SEC document
January 06, 2022 Filed Jan 7, 2022 23:05 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 19,650 $123.49 $2,426,578.50
Disclosure

SEC source: 0001225208-22-000614 · doc4.xml · nonDerivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,001.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

F4 · price: This transaction was executed in multiple trades at prices ranging from $122.99 to $123.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 06, 2022 Filed Jan 7, 2022 23:05 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 12,600 $124.45 $1,568,070.00
Disclosure

SEC source: 0001225208-22-000614 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,651.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $124.00 to $124.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 06, 2022 Filed Jan 7, 2022 23:05 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-000614 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,251.82

Read SEC document
January 06, 2022 Filed Jan 7, 2022 23:05 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 300 $125.17 $37,551.00
Disclosure

SEC source: 0001225208-22-000614 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,751.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $125.07 to $125.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 06, 2022 Filed Jan 7, 2022 23:05 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 45,050 $21.76 $980,288.00
Disclosure

SEC source: 0001225208-22-000614 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233,051.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

Read SEC document
December 22, 2021 Filed Feb 1, 2022 02:25 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-001213 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,399.3995

F1 · shares: This transaction represents an estate gift transferred on December 22, 2021.

Read SEC document
December 20, 2021 Filed Dec 21, 2021 02:34 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 45,050 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-015166 · doc4.xml · derivative · entry 8

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,250

Underlying: Common Stock · 45,050 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.